×

Sign In

Search
Home

Sarepta Therapeutics CEO Ingram to retire by year end

By Thomson Reuters Feb 26, 2026 | 4:05 AM

Feb 25 (Reuters) – Sarepta Therapeutics CEO Douglas Ingram has decided to step down by the end of 2026 or upon the appointment of ‌his replacement, the company said in a regulatory filing.

The company said it has commenced a search for his replacement.

(Reporting by Sneha S K; Editing by Shinjini Ganguli)

CEO of World Economic Forum quits after Epstein ties scrutinised

South Africa's finance minister stresses need for higher growth to draw investment

Norway's wealth fund using AI to screen for ESG risks

US stock futures waver as Nvidia's blockbuster results draw muted response

Deutsche Telekom CEO criticises EU telecom rules overhaul

Amazon refused permission to appeal go-ahead for UK lawsuits from retailers, consumers

Privacy Policy
Terms Of Service

Copyright © 2026. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.